09995.HK
RemeGen Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 80.00
−1.48%Margins
Gross margin
92.7%
EBITDA margin
64.0%
EBIT margin
61.1%
Net margin
72.7%
FCF margin
54.7%
69.5%
Return on equity
58.7%
Return on assets
56.4%
Return on invested capital
0.93x
Asset turnover
HKD 5.2B
Cash from operations
HKD 11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026